drugset / Trial / NCT00432237
Safety and Efficacy Study of MK0974 in the Acute Migraine (0974-016)
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to investigate the efficacy and safety of MK0974 compared to a placebo for acute migraine.
Timeline
- Start
- 2007-03
- Primary completion
- 2007-12
- Completion
- 2007-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Telcagepant | Small molecule | 50 mg | Oral |
| Subject | Telcagepant | Small molecule | 150 mg | Oral |
| Subject | Telcagepant | Small molecule | 300 mg | Oral |